亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Possible candidate population for neoadjuvant chemotherapy in women with advanced ovarian cancer

医学 危险系数 内科学 卵巢癌 置信区间 阶段(地层学) 肿瘤科 人口 回顾性队列研究 浆液性液体 癌症 相对存活率 倾向得分匹配 妇科 队列 癌症登记处 环境卫生 生物 古生物学
作者
Koji Matsuo,Shinya Matsuzaki,David J. Nusbaum,Asaf Maoz,Katsutoshi Oda,Maximilian Klar,Lynda D. Roman,Anil K. Sood
出处
期刊:Gynecologic Oncology [Elsevier BV]
卷期号:160 (1): 32-39 被引量:22
标识
DOI:10.1016/j.ygyno.2020.10.027
摘要

Abstract

Objective

To examine trends and outcomes related to neoadjuvant chemotherapy (NACT) use for advanced ovarian cancer based on patient and tumor factors.

Methods

This retrospective cohort study queried the National Cancer Institute's Surveillance, Epidemiology, and End Results Program to examine women with stage III-IV high-grade serous ovarian carcinoma from 2010 to 2016. Propensity score inverse probability of treatment weighting was used to assess the age-, cancer stage-, and tumor extent-specific survival estimates related to NACT use.

Results

Utilization of NACT has significantly increased in older women (≥65 years; 48.4% relative increase), followed by stage IV disease (35.2% relative increase), and stage III disease (25.0% relative increase) (all, P-trend < 0.05). Women who received NACT had overall survival (OS) similar to those who had primary cytoreductive surgery (PCS) in older women (hazard ratio [HR] 1.07, 95% confidence interval [CI] 0.95–1.20, P = 0.284), stage IV disease (HR 0.96, 95%CI 0.84–1.10, P = 0.564), and more disease extent cases (T3/N1/M1, HR 1.06, 95%CI 0.84–1.32, P = 0.640). Moreover, NACT use was associated with decreased other cause mortality risk compared to PCS in the older women (sub-distribution HR 0.61, 95%CI 0.40–0.94, P = 0.025) and stage IV disease (sub-distribution HR 0.49, 95%CI 0.27–0.90, P = 0.021). In contrast, women who received NACT had decreased OS compared to those who had PCS in the younger group (HR 1.22, 95%CI 1.07–1.38, P = 0.004), stage III disease (HR 1.26, 95%CI 1.13–1.41, P < 0.001), and lesser disease extent cases (T3/N0/M0, HR 1.38, 95%CI 1.20–1.58, P < 0.001).

Conclusion

Our study suggests that survival effect of NACT for advanced ovarian cancer may differ based on patient and tumor factors. In older women, stage IV disease, and greater disease extent, NACT was associated with similar OS compared to PCS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
曲聋五完成签到 ,获得积分0
1秒前
初景的应助被是磊啊采纳,获得20
1秒前
Ballyhooed完成签到,获得积分10
3秒前
4秒前
嘻嘻哈哈的应助被Minnie采纳,获得10
5秒前
康子浩发布了新的文献求助10
7秒前
英俊大树发布了新的文献求助10
10秒前
暖暖发布了新的文献求助10
10秒前
12秒前
14秒前
14秒前
虚心的迎彤完成签到,获得积分10
14秒前
16秒前
雪山大地发布了新的文献求助10
17秒前
Zhou完成签到 ,获得积分10
17秒前
英俊大树完成签到,获得积分10
17秒前
和谐以冬发布了新的文献求助10
18秒前
研友_VZG7GZ的应助被暖暖采纳,获得10
19秒前
CodeCraft的应助被王艳采纳,获得10
22秒前
histamin完成签到,获得积分10
25秒前
27秒前
30秒前
Collice发布了新的文献求助30
35秒前
杏仁核发布了新的文献求助10
36秒前
充电宝的应助被康子浩采纳,获得10
36秒前
ppp发布了新的文献求助10
37秒前
桃里里完成签到,获得积分10
41秒前
42秒前
44秒前
废纸箱发布了新的文献求助10
47秒前
Minnie完成签到,获得积分10
48秒前
50秒前
杏仁核完成签到,获得积分10
51秒前
沧海君发布了新的文献求助10
53秒前
JamesPei的应助被废纸箱采纳,获得10
53秒前
沉静的愫完成签到,获得积分10
55秒前
康子浩发布了新的文献求助10
55秒前
56秒前
彭于晏的应助被沧海云帆采纳,获得10
59秒前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165884
求助须知:如何正确求助?哪些是违规求助? 9559318
关于积分的说明 21749884
捐赠科研通 7756681
什么是DOI,文献DOI怎么找? 3429083
关于科研通互助平台的介绍 2553367
邀请新用户注册赠送积分活动 2473623